scholarly journals Adult HIV/AIDS Patients’ Level of Satisfaction on Pharmaceutical Service: Institutional Prospective Cross Sectional Study

2019 ◽  
Author(s):  
Adey Girmay ◽  
Zelalem Tilahun ◽  
Muluemebet Zinabu Akele ◽  
Solomon Assefa Huluka

Abstract Objective : Patients are essential sources of information to assess the accessibility and effectiveness of pharmaceutical care. Patients’ perception and satisfaction on the care they received has direct influence on treatment adherence. This study was thus aimed to assess HIV/AIDS patients’ level of satisfaction on the pharmaceutical services provided in Zewditu Memorial Hospital, Addis Ababa, Ethiopia. An institution based cross sectional study was conducted from April 16, 2018 to May 16, 2018 in Zewditu Memorial Hospital. Result: Among the total 285 participants enrolled in the study, 172(60.4%) of them were females and the mean age of the participants was 42.5±9.8. The participants of this study received ART service for a mean duration of 7.3±3.5 years. In this study, 26.7%, 13.7%, 38.6%, 13% and 8.1% of the study participants rated the overall satisfaction to the ART pharmaceutical service as excellent, very good, good, fair, and poor, respectively. Participants who were provided information about drug-drug and drug-food interaction were 2.72 times more likely to be satisfied than those who weren’t provided (AOR=2.72, 95%CI : 1.13-6.54).

2019 ◽  
Author(s):  
Adey Girmay ◽  
Zelalem Tilahun ◽  
Muluemebet Zinabu Akele ◽  
solomon Assefa Huluka

Abstract Objective : Patients are essential sources of information to assess the accessibility and effectiveness of pharmaceutical care. Patients’ perception and satisfaction on the care they received has direct influence on treatment adherence. This study was thus aimed to assess HIV/AIDS patients’ level of satisfaction on the pharmaceutical services provided in Zewditu Memorial Hospital, Addis Ababa, Ethiopia. An institution based cross sectional study was conducted from April 16, 2018 to May 16, 2018 in Zewditu Memorial Hospital. Result: Among the total 285 participants enrolled in the study, 172(60.4%) of them were females and the mean age of the participants was 42.5±9.8. The participants of this study received ART service for a mean duration of 7.3±3.5 years. In this study, 26.7%, 13.7%, 38.6%, 13% and 8.1% of the study participants rated the overall satisfaction to the ART pharmaceutical service as excellent, very good, good, fair, and poor, respectively. Participants who were provided information about drug-drug and drug-food interaction were 2.72 times more likely to be satisfied than those who weren’t provided (AOR=2.72, 95%CI : 1.13-6.54).


2019 ◽  
Author(s):  
Demelash Wachamo ◽  
Fisseha Bonja

Abstract Background Opportunistic infections are late complications of HIV infection is the depletion of the immune system. It is a major public health problem and high morbidity AIDS patients die of AIDS-related infections in developing countries like Ethiopia. Identification of opportunistic infections (OIs) is important to develop a specific intervention. Therefore, this study aimed to assess the burden and associated factors of opportunistic infections.Method A facility-based cross-sectional study was conducted on 420 randomly selected HIV/AIDS patients taking anti-retroviral therapy. Data was collected from selected hospitals in Sidama Zone based on population proportion to size. Data was collected by a pre-tested questionnaire and a pre-tested checklist from the medical records of patients. Data entry and analyzed for descriptive and logistic regression models by SPSS v.23. The result declared as statistically significant at p < 0.05.Result The magnitude of opportunistic infections was 39.6%. Major identified OIs was oral candidacies 23.2%, recurrent bacterial pneumonia 21.5%, Herpes zoster 6.3%, and Pulmonary Tuberculosis 6.0%.The magnitude of opportunistic associated with; older age [AOR=2.69, 95% CI: 1.33-5.43], No formal education [AOR=3.12, 95% CI: 1.06-9.25], Low monthly income [AOR=2.27, 95%CI:1.35-3.83], initial CD4 count less than 200 cells/mm3 [AOR=1.91, 95% CI:1.05-3.46), WHO clinical stage II [AOR=2.43, 95% CI:1.34-4.42] and stage III and IV [AOR=4.27, 95% CI: 2.12-8.59], had no extra medicine additional to ART (prophylaxis) had [AOR= 5.91, 95% CI: 3.31-10.56], who interrupt ART medicines [AOR=2.03, 95% CI: 1.09- 3.80] and Khat chewing [AOR=5.48, 95% CI: 2.32-12.96] when compared to their counterparts.Conclusions The overall magnitude of opportunistic infections was high when compared with other studies. Health officials and clinicians need to give attention on the strengthening of the provision if ART with prophylaxis on early-stage and adhrerence, implementation of the TB/HIV collaboration activity, and early initiation of ART to reduce opportunistic infections.


2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Mekuriaw Mesfin Birhan ◽  
Yekoye Abebe

Background. Hypertension imposes stresses on many organs like heart and kidney. However, studies that show the effect of hypertension on the lungs are limited. Objective. To assess pulmonary function status of hypertensive patients aged 30-64 years at Zewditu Memorial Hospital, 2017. Methods. Hospital based comparative cross-sectional study was conducted on 61 hypertensive patients (cases) and 61 nonhypertensive clients (controls) aged 30-64 years. Computerized spirometry was done in all cases and controls which were selected by systematic sampling technique. The study was conducted from January 20, 2017, to May 25, 2017. Result. The values of FVC, FEV1, and FEF25-75% were 3.52±1.02 liters, 2.97±0.89 liters, and 3.34±1.3 liters/second in hypertensive patients and 4.31±0.82 liters, 3.54±0.7 liters, and 3.94±1.09 liters/second in controls, respectively. These values were significantly lower (p<0.05) in hypertensive patients compared to controls. Restrictive pulmonary defect was dominant in hypertensive patients. FEV1% which was 85%±7% in hypertensive patients and 82%±5% in controls was significantly higher (p<0.05) in hypertensive patients compared to controls. Conclusion. Hypertensive patients exhibit lower pulmonary function values. Routine check-up of the pulmonary function status of such patients should be done to prevent undesired outcomes.


2020 ◽  
Vol 35 (1) ◽  
pp. 59-66
Author(s):  
Arebu Issa Bilal ◽  
Bruck Messele ◽  
Dawit Teshome ◽  
Zelalem Tilahun ◽  
Teferi Gedif Fenta

In spite of an increase in the health service coverage of the country, studies reported that significant proportion of the Ethiopian population still relies on traditional medicine, particularly on the herbal aspect, for their healthcare. The aim of the present study was to determine the extent of the concomitant use of herbal medicines with modern antiretroviral medicines and identify the commonly used herbs among patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) in Ethiopia. A cross-sectional study was conducted from May to June, 2017 among HIV/AIDS patients in five hospitals selected from four regions and one city Administration (Addis Ababa). A total of 768 HIV/AIDS patients were successfully interviewed and included in the analysis. Most 480 (62.5%) of them were on tenofovir-disoproxil fumarate (TDF) plus lamivudine (3TC)and efavirenz (EFV) regimen. Two hundred nineteen (28.5%) patients reported that they had used herbal medicines to treat their illness; of these 145 (66.2%) used herbal products along with modern medicine. Of those who reported to have used herbal medicine with modern medicine, 53 (40.8%) claimed that they took the herbal medicines for the treatment of HIV/AIDS, while 51(39.2%) used for treating co-morbid diseases. Only 33 (15.0%) of those who used herbal medicines along with modern drugs discussed the issue either with their physicians or pharmacists. A total of 31 plant species were reported to be used for the treatment as well as alleviation of symptoms associated with the disease. The most commonly cited herbal medicines that  have been used by HIV/AIDS patients to treat their comorbid diseases were Moringa stenopetala (Baker f.) Cufod. (Moringaceae) (35.6%) followed by Ocimum lamiifolium Hochst. (Lamiaceae) (18.0%), Zheneria scabra Sond. (Cucurbitaceae) (7.2%), Allium sativum L. (Alliaceae) (5.7%), and Ruta chalapensis L. (Rutaceae) (5.7%). The study revealed that close to one-third of HIV/AIDS patients interviewed reported use of herbal medicine and almost two-thirds of them did so concomitantly with modern medicine. Only small percentage of the patients who used herbal medicines along with modern drugs disclose the use either to their treating physicians or to counselling pharmacists. Practitioners involved in antiretroviral therapy (ART) clinics, therefore, need to inquire information related to the use of herbal medicines and accordingly advise the patients. Keywords: HIV/AIDS, medicinal plant, cross-sectional study, concomitant use, Ethiopia  


Sign in / Sign up

Export Citation Format

Share Document